She said the goal was not rapid weight loss
The efficacy and safety profile of naltrexone-bupropion has been established by several multicentre randomised double-blind placebo-controlled trials in the Contrave Obesity Research (COR) programme, including the Contrave Obesity Research-I (COR-I) study, the Contrave Obesity Research-II (COR-II) study, and the Contrave Obesity Research-Intensive Behavior Modification study (COR-BMOD) [9,10,11]
All research must be conducted in accordance with applicable institutional, local, and federal regulations by qualified professionals
Even with advances in technology, many patients experience recurrence within a year, highlighting the need for novel strategies
Cell Mol Immunol (2011) 8:21325
To learn more about your options, you can explore Edens GLP-1 weight loss program, where licensed providers determine whether treatment may be appropriate as part of a broader care plan